showed that a certain monoclonal anti-Tg antibody profile was unable to distinguish between normal Tg and Tg from patients with Graves’ disease, follicular adenoma, or follicular carcinoma, but exhibited very weak binding to Tg from patients with papillary carcinoma (44). The gene discussed is TG; the disease is thyroid gland follicular carcinoma.